enrofloxacin has been researched along with Insulin Sensitivity in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Becker, KG; Biragyn, A; Bodogai, M; Carlson, O; Chen, C; Chen, W; de Cabo, R; Egan, J; Ferrucci, L; Gurung, M; Gusev, F; Kim, K; Kim, Y; Lee-Chang, C; Mack, M; Mattison, JA; Meade, T; Morgun, A; Moritoh, K; O'Connell, J; Perdue, K; Rogaev, E; Shulzhenko, N; Trinchieri, G; Vaughan, K; White, J; Wu, J | 1 |
1 other study(ies) available for enrofloxacin and Insulin Sensitivity
| Article | Year |
|---|---|
Commensal bacteria contribute to insulin resistance in aging by activating innate B1a cells.
Topics: Aging; Animals; Bacteria; Butyrates; Cell Line; Dysbiosis; Enrofloxacin; Female; Gastrointestinal Microbiome; Immunity, Innate; Insulin Resistance; Macaca; Mice, Inbred C57BL; Monocytes; Omentum; Receptors, CCR2 | 2018 |